Bank of New York Mellon Corp

Bank

Position in VOR — Vor Biopharma Inc.

CIK 1390777 NEW YORK, NY

Position in VOR

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$1,799,060

+$1,551,276 QoQ

Shares Held

97,722

+1769.2% QoQ

Ownership

0.165%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#35

of 101 holders

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 94% Shared 0% None 6%

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. VOR ranks #159 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,672,623	$830,842,010
2	REGN	Regeneron Pharmaceuticals, Inc.	758,492	$472,950,091
3	JAZZ	Jazz Pharmaceuticals plc	1,578,013	$380,253,782
4	ALNY	Alnylam Pharmaceuticals, Inc.	492,071	$148,128,128
5	INSM	INSMED Inc	1,312,756	$139,966,036
6	MRNA	Moderna, Inc.	1,701,675	$119,168,293
7	RVMD	Revolution Medicines, Inc.	601,056	$112,565,759
8	INCY	Incyte Corp	972,825	$110,279,435

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,799,060	97,722	-6.5%	Shares	Defined	2026-08-06
2024-03-31	$247,784	104,551	-3.4%	Shares	Defined	2024-04-25
2023-12-31	$243,470	108,209	0.0%	Shares	Defined	2024-01-29
2023-09-30	$229,402	108,209	0.0%	Shares	Defined	2023-10-24
2023-06-30	$334,365	108,209	+783.7%	Shares	Defined	2023-08-03
2023-03-31	$65,878	12,245	0.0%	Shares	Defined	2023-05-09
2022-12-31	$81,429	12,245	-77.9%	Shares	Defined	2023-02-14
2022-03-31	$334,464	55,375	-2.7%	Shares	Defined	2022-05-11
2021-12-31	$661,526	56,930	+9.0%	Shares	Defined	2022-02-11
2021-09-30	$819,294	52,251	+53.8%	Shares	Defined	2021-11-18
2021-06-30	$633,409	33,963	+12.7%	Shares	Defined	2021-08-11
2021-03-31	$1,299,076	30,141	—	Shares	Defined	2021-05-13
No filing history on record for this holder in this stock.